Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males

Authors:

Abstract
We investigated the clinical usefulness of HbA1c in screening an average-risk group p < 0.05). The incidence of adenomatous polyp increased with increasing quartiles of HbA1C as follows: first quartile (19.9%, HbA1c 4.0–5.0), second quartile (27.8%, HbA1c 5.1–5.3), third quartile (32.7%, HbA1c 5.4–5.5), and fourth quartile (34.9%, HbA1c = 5.6–8.8)(p = 0.008). When combining quartile of HbA1c and age (40 s vs. 50 s) according to HbA1C levels, the odds ratio for adenomatous polyp in subjects in their 40 s with HbA1c <5.4% was significantly lower than that in subjects in their 50 s. However, the odds ratio for adenomatous polyp in subjects in their 40 s with HbA1c ≥5.4% was similar to that in subjects in their 50 s with average risk for CRC. An elevated HbA1c may be useful as a clinical predictor of adenomatous polyps in male subjects <50 years of age who have average risk for CRC.

This publication has 20 references indexed in Scilit: